About 60% of participants with long COVID attributed their work loss to their symptoms.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Lower percentages of US children visited an emergency department (ED) for any indication amid the COVID-19 pandemic, while adolescent girls accounted for the largest hikes in visits for mental illness, according to two Centers for Disease Control and Prevention (CDC) studies published late last week in Morbidity and Mortality Weekly Report (MMWR).
In the ivermectin group, 22% became severely ill, vs 17% in the standard-care group.
A meeting of 53,000 people was not a super-spreader, with social contact outside the center being a risk factor.
In US COVID-19 developments, Hawaii is the only state with a mask mandate still in place.
The risk of hospitalization, intensive care unit (ICU) admission, and death was much lower among more than 9,000 Canadian COVID-19 patients infected with the Omicron variant than among matched Delta patients, according to a study published yesterday in JAMA.
The risk of hospitalization or death with Omicron was 41% of—and the risk of death was one-tenth of—that of Delta.
An analysis of prescribing data from more than 80 countries found that global antimicrobial consumption declined prior to the COVID-19 pandemic, researchers reported today in the Journal of Antimicrobial Chemotherapy.
"We need to ... address these conditions now before they balloon into a much larger mental health crisis."
One study shows more than 90% vaccine protection post-infection, even when the shot follows infection by 18 months.
The University of Wisconsin and Purdue University announce the easing of mask requirements.
A new review of 15 studies analyzed by the UK Health Security Agency (UKHSA) shows COVID-19 vaccination is protective against developing symptoms of long COVID, or symptoms lasting longer than 4 weeks after the initial infection.
